InMed Pharmaceuticals Inc. (TSX: IN) (OTCQX: IMLFF), is a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol. The company introduced details of IntegraSynTM, the Company’s new […]





